EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Prostate cancer–induced endothelial-cell-to-osteoblast transition drives immunosuppression in the bone–tumor microenvironment through Wnt pathway–induced M2 macrophage polarization

Guoyu Yu iD, Paul G Corn, Celia Sze Ling Mak, Xin Liang, Miao Zhang, Patricia Troncoso iD, Jian H Song iD, Song-Chang Lin iD, Xingzhi Song, Jingjing Liu, Jianhua Zhang, Christopher J Logothetis und 4 weitere

Proceedings of the National Academy of Sciences · 13.08.2024 · 121 (33)

DOI: 10.1073/pnas.2402903121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 05.08.2024. Verfasst von Guoyu Yu und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. Hauptthemen laut MEDLINE: Tumor Microenvironment, Bone Neoplasms, Wnt Signaling Pathway, Macrophages. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, HHS | NIH | National Cancer Institute (NCI), Cancer Prevention and Research Institute of Texas (CPRIT).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune checkpoint therapy has limited efficacy for patients with bone-metastatic castration-resistant prostate cancer (bmCRPC). To improve immunotherapy for bmCRPC, we aimed to identify the mechanism of bmCRPC-induced changes in the immune microenvironment. Among bmCRPC patients, higher levels of a 32-gene M2-like macrophage signature in bone metastasis samples correlated with shorter overall survival. Immunohistochemistry showed that CD206-positive (CD206 + ) macrophages were enriched in bmCRPC bone biopsy specimens compared with primary tumors or lymph node metastases. In preclinical osteogenic prostate cancer (Pca) xenograft models, CD206 + macrophages were recruited to areas with tumor-induced bone. RNA sequencing (RNAseq) analysis showed higher expression of an M2-like gene signature, with activated canonical and noncanonical Wnt pathways, in tumor-associated macrophages isolated from osteogenic tumors (bone-TAMs) than in TAMs isolated from nonosteogenic tumors (ctrl-TAMs). Mechanistic studies showed that endothelial cells (ECs) that had undergone EC-to-osteoblast (EC-to-OSB) transition, the precursors of tumor-induced OSBs, produced paracrine factors, including Wnts, CXCL14, and lysyl oxidase, which induced M2 polarization and recruited M2-like TAMs to the bone–tumor microenvironment (bone-TME). Bone-TAMs suppressed CD8 + T cells’ proliferation and cytolytic activity, and these effects were partially reversed by treating bone-TAMs with Wnt inhibitors. Genetic or pharmacological inhibition of Pca–induced EC-to-OSB transition reduced the levels of M2-like macrophages in osteogenic tumors. Our study demonstrates that Pca–induced EC-to-OSB transition drives immunosuppression in the bone-TME, suggesting that therapies that reduce Pca–induced bone formation may improve immunotherapeutic outcomes for bmCRPC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentBone NeoplasmsWnt Signaling PathwayMacrophagesEndothelial CellsOsteoblastsMaleHumansAnimalsMiceProstatic Neoplasms, Castration-ResistantCell Line, TumorProstatic NeoplasmsTumor-Associated Macrophages

Stichwörter der Autor:innen

EC-to-OSB transitionbone metastasismacrophageprostate cancertumor-induced bone

Autor:innen und Institutionen

  • Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
  • Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
  • Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
  • Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
  • MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX 77030.

ORCID-Profile: Guoyu Yu, Patricia Troncoso, Jian H Song, Song-Chang Lin

Förderung

  • NCI NIH HHS
  • HHS | NIH | National Cancer Institute (NCI)
  • Cancer Prevention and Research Institute of Texas (CPRIT)
  • DOD | USA | MEDCOM | CDMRP | DOD Prostate Cancer Research Program (PCRP)

Zitieren

APA

Yu, G., Corn, P. G., Mak, C. S. L., Liang, X., Zhang, M., Troncoso, P., Song, J. H., Lin, S. C., Song, X., Liu, J., Zhang, J., Logothetis, C. J., Melancon, M. P., Panaretakis, T., Wang, G., & Lin, S. H. (2024). Prostate cancer–induced endothelial-cell-to-osteoblast transition drives immunosuppression in the bone–tumor microenvironment through Wnt pathway–induced M2 macrophage polarization. Proceedings of the National Academy of Sciences, 121(33). https://doi.org/10.1073/pnas.2402903121

Vancouver

Yu G, Corn PG, Mak CSL, Liang X, Zhang M, Troncoso P, et al. Prostate cancer–induced endothelial-cell-to-osteoblast transition drives immunosuppression in the bone–tumor microenvironment through Wnt pathway–induced M2 macrophage polarization. Proceedings of the National Academy of Sciences. 2024;121(33). doi:10.1073/pnas.2402903121

BibTeX
@article{Yu2024,
  author = {Yu, Guoyu and Corn, Paul G and Mak, Celia Sze Ling and Liang, Xin and Zhang, Miao and Troncoso, Patricia and Song, Jian H and Lin, Song-Chang and Song, Xingzhi and Liu, Jingjing and Zhang, Jianhua and Logothetis, Christopher J and Melancon, Marites P and Panaretakis, Theocharis and Wang, Guocan and Lin, Sue-Hwa},
  title = {Prostate cancer–induced endothelial-cell-to-osteoblast transition drives immunosuppression in the bone–tumor microenvironment through Wnt pathway–induced M2 macrophage polarization},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2024},
  volume = {121},
  number = {33},
  doi = {10.1073/pnas.2402903121}
}
Kostenlos starten →